{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:18:59Z","timestamp":1773955139111,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T00:00:00Z","timestamp":1347667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s10238-012-0207-4","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T02:08:33Z","timestamp":1347674913000},"page":"245-250","source":"Crossref","is-referenced-by-count":6,"title":["Clinical significance and prevalence of anti-Saccharomyces cerevisiae antibody in Chinese patients with primary biliary cirrhosis"],"prefix":"10.1007","volume":"13","author":[{"given":"Chaojun","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuiwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,15]]},"reference":[{"key":"207_CR1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261\u20131273","journal-title":"N Engl J Med"},{"key":"207_CR2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.21749","volume":"46","author":"KN Lazaridis","year":"2007","unstructured":"Lazaridis KN, Juran BD, Boe GM et al (2007) Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology 46:785\u2013792","journal-title":"Hepatology"},{"key":"207_CR3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T et al (2007) Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45:118\u2013127","journal-title":"Hepatology"},{"key":"207_CR4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-8411(03)00033-7","volume":"20","author":"K Miyachi","year":"2003","unstructured":"Miyachi K, Hankins RW, Matsushima H et al (2003) Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J Autoimmun 20:247\u2013254","journal-title":"J Autoimmun"},{"key":"207_CR5","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.3748\/wjg.v16.i29.3616","volume":"16","author":"CJ Hu","year":"2010","unstructured":"Hu CJ, Zhang FC, Li YZ et al (2010) Primary biliary cirrhosis: what do autoantibodies tell us? World J Gastroenterol 16:3616\u20133629","journal-title":"World J Gastroenterol"},{"key":"207_CR6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1373\/clinchem.2005.058560","volume":"52","author":"X Bossuyt","year":"2006","unstructured":"Bossuyt X (2006) Serologic markers in inflammatory bowel disease. Clin Chem 52:171\u2013181","journal-title":"Clin Chem"},{"key":"207_CR7","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1572-0241.2006.00840.x","volume":"101","author":"GE Reese","year":"2006","unstructured":"Reese GE, Constantinides VA, Simillis C et al (2006) Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol 101:2410\u20132422","journal-title":"Am J Gastroenterol"},{"key":"207_CR8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2249.2003.02166.x","volume":"132","author":"P Muratori","year":"2003","unstructured":"Muratori P, Muratori L, Guidi M et al (2003) Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 132:473\u2013476","journal-title":"Clin Exp Immunol"},{"key":"207_CR9","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s10620-007-0092-y","volume":"53","author":"W Sakly","year":"2008","unstructured":"Sakly W, Jeddi M, Ghedira I (2008) Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis. Dig Dis Sci 53:1983\u20131987","journal-title":"Dig Dis Sci"},{"key":"207_CR10","first-page":"37","volume":"55","author":"S Fagoonee","year":"2009","unstructured":"Fagoonee S, De Luca L, De Angelis C et al (2009) Anti-Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis. Minerva Gastroenterol Dietol 55:37\u201340","journal-title":"Minerva Gastroenterol Dietol"},{"key":"207_CR11","doi-asserted-by":"crossref","first-page":"e12957","DOI":"10.1371\/journal.pone.0012957","volume":"5","author":"M Papp","year":"2010","unstructured":"Papp M, Norman GL, Vitalis Z et al (2010) Presence of anti-microbial antibodies in liver cirrhosis\u2014a tell-tale sign of compromised immunity? PLoS ONE 5:e12957","journal-title":"PLoS ONE"},{"key":"207_CR12","first-page":"129","volume":"5","author":"HY Liu","year":"2006","unstructured":"Liu HY, Deng AM, Zhou Y et al (2006) Analysis of HLA alleles polymorphism in Chinese patients with primary biliary cirrhosis. Hepatobiliary Pancreat Dis Int 5:129\u2013132","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"207_CR13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0168-8278(02)00440-3","volume":"38","author":"P Invernizzi","year":"2003","unstructured":"Invernizzi P, Battezzati PM, Crosignani A et al (2003) Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J Hepatol 38:401\u2013406","journal-title":"J Hepatol"},{"key":"207_CR14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","volume":"31","author":"EJ Heathcote","year":"2000","unstructured":"Heathcote EJ (2000) Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 31:1005\u20131013","journal-title":"Hepatology"},{"key":"207_CR15","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2036.2004.02258.x","volume":"20","author":"V Annese","year":"2004","unstructured":"Annese V, Piepoli A, Perri F et al (2004) Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features. Aliment Pharmacol Ther 20:1143\u20131152","journal-title":"Aliment Pharmacol Ther"},{"key":"207_CR16","doi-asserted-by":"crossref","first-page":"27393","DOI":"10.1016\/S0021-9258(19)61523-1","volume":"275","author":"E Cabiscol","year":"2000","unstructured":"Cabiscol E, Piulats E, Echave P et al (2000) Oxidative stress promotes specific protein damage in Saccharomyces cerevisiae. J Biol Chem 275:27393\u201327398","journal-title":"J Biol Chem"},{"key":"207_CR17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1478-3231.2007.01651.x","volume":"28","author":"B Liu","year":"2008","unstructured":"Liu B, Shi XH, Zhang FC et al (2008) Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis. Liver Int 28:233\u2013239","journal-title":"Liver Int"},{"key":"207_CR18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","volume":"98","author":"P Muratori","year":"2003","unstructured":"Muratori P, Muratori L, Ferrari R et al (2003) Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 98:431\u2013437","journal-title":"Am J Gastroenterol"},{"key":"207_CR19","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1007\/s10620-011-1756-1","volume":"56","author":"C Hu","year":"2011","unstructured":"Hu C, Deng C, Song G et al (2011) Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis. Dig Dis Sci 56:3357\u20133363","journal-title":"Dig Dis Sci"},{"key":"207_CR20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00011-008-8139-x","volume":"58","author":"R Marrakchi","year":"2009","unstructured":"Marrakchi R, Bougatef K, Moussa A et al (2009) 3020insC insertion in NOD2\/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn\u2019s disease in Tunisian population. Inflamm Res 58:218\u2013223","journal-title":"Inflamm Res"},{"issue":"9","key":"207_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2350-9-81","volume":"21","author":"P Gaj","year":"2008","unstructured":"Gaj P, Habior A, Mikula M et al (2008) Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn\u2019s disease in Polish patients. BMC Med Genet 21(9):81","journal-title":"BMC Med Genet"},{"key":"207_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10350-004-0747-0","volume":"48","author":"V Annese","year":"2005","unstructured":"Annese V, Piepoli A, Latiano A et al (2005) HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis Colon Rectum 48:57\u201364","journal-title":"Dis Colon Rectum"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-012-0207-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-012-0207-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-012-0207-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T04:23:32Z","timestamp":1643430212000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-012-0207-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,15]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["207"],"URL":"https:\/\/doi.org\/10.1007\/s10238-012-0207-4","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,15]]}}}